Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT DISHMAN PHARMA WOCKHARDT/
DISHMAN PHARMA
 
P/E (TTM) x -16.8 30.0 - View Chart
P/BV x 2.7 3.3 80.1% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 WOCKHARDT   DISHMAN PHARMA
EQUITY SHARE DATA
    WOCKHARDT
Mar-23
DISHMAN PHARMA
Mar-16
WOCKHARDT/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs316374 84.3%   
Low Rs145129 112.8%   
Sales per share (Unadj.) Rs184.0197.0 93.4%  
Earnings per share (Unadj.) Rs-43.121.2 -203.4%  
Cash flow per share (Unadj.) Rs-25.734.7 -74.0%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Avg Dividend yield %00.8 0.0%  
Book value per share (Unadj.) Rs231.7179.9 128.8%  
Shares outstanding (eoy) m144.0980.70 178.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.3 98.0%   
Avg P/E ratio x-5.311.9 -45.0%  
P/CF ratio (eoy) x-9.07.3 -123.8%  
Price / Book Value ratio x1.01.4 71.1%  
Dividend payout %09.4 -0.0%   
Avg Mkt Cap Rs m33,20220,307 163.5%   
No. of employees `000NANA-   
Total wages/salary Rs m6,3705,355 119.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m26,51015,898 166.8%  
Other income Rs m1,220265 459.7%   
Total revenues Rs m27,73016,163 171.6%   
Gross profit Rs m-1,9304,103 -47.0%  
Depreciation Rs m2,5101,091 230.1%   
Interest Rs m3,020944 319.8%   
Profit before tax Rs m-6,2402,334 -267.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-30624 -4.8%   
Profit after tax Rs m-6,2101,710 -363.2%  
Gross profit margin %-7.325.8 -28.2%  
Effective tax rate %0.526.7 1.8%   
Net profit margin %-23.410.8 -217.8%  
BALANCE SHEET DATA
Current assets Rs m19,14011,018 173.7%   
Current liabilities Rs m34,3509,517 360.9%   
Net working cap to sales %-57.49.4 -607.7%  
Current ratio x0.61.2 48.1%  
Inventory Days Days3957 69.1%  
Debtors Days Days113 313.8%  
Net fixed assets Rs m48,67018,787 259.1%   
Share capital Rs m720161 446.1%   
"Free" reserves Rs m32,66014,354 227.5%   
Net worth Rs m33,38014,516 230.0%   
Long term debt Rs m2,2404,189 53.5%   
Total assets Rs m70,75029,805 237.4%  
Interest coverage x-1.13.5 -30.7%   
Debt to equity ratio x0.10.3 23.3%  
Sales to assets ratio x0.40.5 70.2%   
Return on assets %-4.58.9 -50.6%  
Return on equity %-18.611.8 -157.9%  
Return on capital %-9.017.5 -51.6%  
Exports to sales %024.9 0.0%   
Imports to sales %3.53.7 92.8%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs m920594 154.8%   
Fx inflow Rs m7304,952 14.7%   
Fx outflow Rs m920697 132.1%   
Net fx Rs m-1904,255 -4.5%   
CASH FLOW
From Operations Rs m1,5302,786 54.9%  
From Investments Rs m-1,250-1,529 81.8%  
From Financial Activity Rs m-3,150-941 334.8%  
Net Cashflow Rs m-2,800317 -884.7%  

Share Holding

Indian Promoters % 54.9 61.4 89.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.5 23.0 19.5%  
FIIs % 4.2 12.0 34.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.1 38.6 116.8%  
Shareholders   161,813 52,291 309.4%  
Pledged promoter(s) holding % 74.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Wockhardt vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Wockhardt vs Dishman Pharma Share Price Performance

Period Wockhardt Dishman Pharma S&P BSE HEALTHCARE
1-Day 4.99% 2.87% 1.18%
1-Month 0.15% -2.45% -0.75%
1-Year 290.07% 96.38% 61.82%
3-Year CAGR 13.79% 89.34% 18.16%
5-Year CAGR 7.92% 38.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the Wockhardt share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of Wockhardt hold a 54.9% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Wockhardt and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, Wockhardt paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of Wockhardt, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.